Robert B Hawkins1, J Hunter Mehaffey1, Eric J Charles1, John A Kern2, D Scott Lim3, Nicholas R Teman2, Gorav Ailawadi4. 1. Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia; Center for Health Policy, University of Virginia, Charlottesville, Virginia. 2. Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia. 3. Department of Cardiology, University of Virginia, Charlottesville, Virginia. 4. Division of Thoracic and Cardiovascular Surgery, Department of Surgery, University of Virginia, Charlottesville, Virginia. Electronic address: gorav@virginia.edu.
Abstract
BACKGROUND: Frailty is an important predictor of outcomes after cardiac surgery, but utility is limited by difficult assessment and quantification. We hypothesize that sarcopenia defined as psoas muscle cross-sectional area is a useful predictor of surgical aortic valve replacement outcomes in moderate to high-risk patients. METHODS: Moderate to high risk patients (predicted risk of mortality greater than 3%) who underwent surgical aortic valve replacement with or without coronary artery bypass were extracted from an institutional database (2009 to 2016). Psoas index was calculated as the cross-sectional area of the psoas muscle at the L4 vertebral level normalized to body surface area. Patients were stratified by sarcopenia status, defined as less than 25th sex-specific percentile. Multivariable regression analysis identified risk-adjusted associations with psoas index using The Society of Thoracic Surgeons predicted risk scores. RESULTS: Of the 240 patients included, the median predicted risk of mortality was 6%, median age 80 years, and 40% were female. Patients with (33.3%) and without (66.7%) sarcopenia had equivalent baseline risk (median predicted risk of mortality 5.7% versus 6.0%, p = 0.29). Patients with sarcopenia had higher 1-year mortality (31.9% versus 16.9% p = 0.03). Psoas index significantly predicted risk-adjusted 1-year mortality (odds ratio 0.84, p = 0.02) and long-term mortality (hazard ratio 0.92, p = 0.04), as well as risk-adjusted major morbidity, prolonged ventilation, length of stay, discharge to a facility, and hospital cost. Finally, psoas index measurements were highly reproducible (Pearson correlation coefficient 0.944). CONCLUSIONS: Psoas index is an easily obtained and reproducible measure of frailty that predicts risk-adjusted resource utilization, morbidity, and long-term mortality. Psoas index may improve procedural selection and risk adjustment in high-risk patients with aortic valve disease.
BACKGROUND: Frailty is an important predictor of outcomes after cardiac surgery, but utility is limited by difficult assessment and quantification. We hypothesize that sarcopenia defined as psoas muscle cross-sectional area is a useful predictor of surgical aortic valve replacement outcomes in moderate to high-risk patients. METHODS: Moderate to high risk patients (predicted risk of mortality greater than 3%) who underwent surgical aortic valve replacement with or without coronary artery bypass were extracted from an institutional database (2009 to 2016). Psoas index was calculated as the cross-sectional area of the psoas muscle at the L4 vertebral level normalized to body surface area. Patients were stratified by sarcopenia status, defined as less than 25th sex-specific percentile. Multivariable regression analysis identified risk-adjusted associations with psoas index using The Society of Thoracic Surgeons predicted risk scores. RESULTS: Of the 240 patients included, the median predicted risk of mortality was 6%, median age 80 years, and 40% were female. Patients with (33.3%) and without (66.7%) sarcopenia had equivalent baseline risk (median predicted risk of mortality 5.7% versus 6.0%, p = 0.29). Patients with sarcopenia had higher 1-year mortality (31.9% versus 16.9% p = 0.03). Psoas index significantly predicted risk-adjusted 1-year mortality (odds ratio 0.84, p = 0.02) and long-term mortality (hazard ratio 0.92, p = 0.04), as well as risk-adjusted major morbidity, prolonged ventilation, length of stay, discharge to a facility, and hospital cost. Finally, psoas index measurements were highly reproducible (Pearson correlation coefficient 0.944). CONCLUSIONS: Psoas index is an easily obtained and reproducible measure of frailty that predicts risk-adjusted resource utilization, morbidity, and long-term mortality. Psoas index may improve procedural selection and risk adjustment in high-risk patients with aortic valve disease.
Authors: John D Puskas; Patrick D Kilgo; Vinod H Thourani; Omar M Lattouf; Edward Chen; J David Vega; William Cooper; Robert A Guyton; Michael Halkos Journal: Ann Thorac Surg Date: 2011-10-13 Impact factor: 4.330
Authors: Stefan Stortecky; Andreas W Schoenenberger; André Moser; Bindu Kalesan; Peter Jüni; Thierry Carrel; Seraina Bischoff; Christa-Maria Schoenenberger; Andreas E Stuck; Stephan Windecker; Peter Wenaweser Journal: JACC Cardiovasc Interv Date: 2012-05 Impact factor: 11.195
Authors: T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover Journal: Ann Thorac Surg Date: 2002-02 Impact factor: 4.330
Authors: Michael Goldfarb; Melissa Bendayan; Lawrence G Rudski; Jean-Francois Morin; Yves Langlois; Felix Ma; Kevin Lachapelle; Renzo Cecere; Benoit DeVarennes; Christo I Tchervenkov; James M Brophy; Jonathan Afilalo Journal: Can J Cardiol Date: 2017-03-30 Impact factor: 5.223
Authors: Rebecca C Dirks; Brandy L Edwards; Elizabeth Tong; Basil Schaheen; Florence E Turrentine; Amber Shada; Philip W Smith Journal: J Surg Res Date: 2016-08-10 Impact factor: 2.192
Authors: Raghavendra Paknikar; Jeffrey Friedman; David Cron; G Michael Deeb; Stanley Chetcuti; P Michael Grossman; Stewart Wang; Michael Englesbe; Himanshu J Patel Journal: J Thorac Cardiovasc Surg Date: 2015-11-21 Impact factor: 5.209
Authors: Neda Amini; Gaya Spolverato; Rohan Gupta; Georgios A Margonis; Yuhree Kim; Doris Wagner; Neda Rezaee; Matthew J Weiss; Christopher L Wolfgang; Martin M Makary; Ihab R Kamel; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2015-04-30 Impact factor: 3.452
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Robert B Hawkins; Emily A Downs; Lily E Johnston; J Hunter Mehaffey; Clifford E Fonner; Ravi K Ghanta; Alan M Speir; Jeffrey B Rich; Mohammed A Quader; Leora T Yarboro; Gorav Ailawadi Journal: Ann Thorac Surg Date: 2017-04-24 Impact factor: 4.330
Authors: Jared P Beller; Robert B Hawkins; J Hunter Mehaffey; William Z Chancellor; Clifford E Fonner; Alan M Speir; Mohammed A Quader; Jeffrey B Rich; Leora T Yarboro; Nicholas R Teman; Gorav Ailawadi Journal: J Thorac Cardiovasc Surg Date: 2019-02-11 Impact factor: 5.209
Authors: Ryan Howard; Yue S Yin; Lane McCandless; Stewart Wang; Michael Englesbe; David Machado-Aranda Journal: J Am Coll Surg Date: 2018-10-22 Impact factor: 6.113
Authors: Andrew D Brown; Ben Li; Samantha Gabriel; Robert J Cusimano; Jennifer Chung; Eric Horlick; Mark D Osten; Maral Ouzounian; Graham Roche-Nagle Journal: CJC Open Date: 2021-09-16
Authors: Jessica Avery Lee; Bobby Yanagawa; Kevin R An; Rakesh C Arora; Subodh Verma; Jan O Friedrich Journal: J Cardiothorac Surg Date: 2021-06-25 Impact factor: 1.637